CBR Pharma Insights

Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies $2995

Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies Summary GBI Research’s latest report, “Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies”, provides key insights into the global telehealth ...Read the full article

1st March, 2016 • CBR Pharma Insights

 

Evolving Market Access Strategies – Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets $2995

1st January, 2016 • CBR Pharma Insights

 

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) – Pipeline Review, H1 2014 $2000

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) – Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade’s Disease) – Pipeline Review, ...Read the full article

31st January, 2014 • Global Markets Direct

 

Oncology Development Strategies – Considerable commercial potential but specific needs must be addressed $3900

The oncology therapeutic area has seen significant development and advances over the last decade. However, oncology has one of the lowest overall clinical success rates of all therapy areas with ...Read the full article

15th January, 2013 • CBR Pharma Insights

 

Opioids Market to 2018 – Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market $3500

Opioids Market to 2018 – Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market Summary Leading business intelligence provider GBI Research has released its latest research ...Read the full article

4th January, 2013 • GBI Research

 

Let’s get started...

Broker Rating Markets Available Fees Open an Account
Kawase Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 3.60 /5
(15 votes cast)
Loading...
Shares, Indices, Forex and Oil Spread From 0.1 and 0.2% Commission Visit Website
Plus500 Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.48 /5
(452 votes cast)
Loading...
Stocks, Commodities, Indices and Forex. Zero commissions. No monthly fees. $10 USD fee for unused account for a period of three months. Visit Website
MaxFx Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.69 /5
(88 votes cast)
Loading...
Indices, Forex, Metals, Shares From 0.1 Raw Interbank Spread Visit Website
Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.